In IBD, NR4A2 was considered as a negative regulator of immune response, and deletion of NR4A2 in T cells was confirmed to attenuate Tregs induction and led to aberrant increase of Th1 cells, which might partly exacerbate the colonic inflammation.154. The gene discussed is NR4A2; the disease is inflammatory bowel disease.